Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page
- Check4 days agoChange DetectedThe study page no longer displays the condition 'Multiple myeloma' and the related topic 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check11 days agoChange DetectedRemoved a MedlinePlus Genetics topic entry on Multiple Myeloma, narrowing the page’s scope and its genetics-related content.SummaryDifference0.3%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

- Check33 days agoChange DetectedUpdate terminology from Plasma cell myeloma to Multiple myeloma and bump revision from v3.0.2 to v3.1.0.SummaryDifference0.3%

- Check40 days agoChange DetectedAdded a MedlinePlus Genetics topic covering multiple myeloma, expanding core medical content.SummaryDifference0.4%

- Check47 days agoChange DetectedUpdate to Revision: v3.0.2; the old Revision: v3.0.1 was removed and the 'Back to Top' element was deleted, with no other substantive changes.SummaryDifference0.3%

Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.